Nanomedicine: the best practices — the latest technologies and opportunities

Under the framework of the EU Jean Monnet Project, European, American and University of Miami experts in Nanotechnology in medicine will meet with faculty, scientists, and the Miami-Dade Community at large. This panel will discuss the impact of nanotechnology on medicine and its implication for the future in healthcare in Europe and in the United States. During the workshop, participants will have the opportunity to discover the latest calls on “Nanotechnology” offered by the European Commission under the framework programme for research and innovation, Horizon 2020.

This event is jointly sponsored by the Miami-Florida Jean Monnet Center of Excellence, FIU and the EU Jean Monnet Project; and co-sponsored by the Dr. John T. MacDonald Foundation, Biomedical Nanotechnology Institute, BioNIUM, the Miller School of Medicine, University of Miami, the Miami Scientific Italian Community; the Consulate General of France in Miami, the Embassy of France in the United States, Office of Science and Technology, Washington DC; AFT Téléthon; the Society for Brain Mapping and Therapeutics; the Koch Institute for Integrative Cancer Research at MIT, the Marble Center for Cancer NanoMedicine; BILAT USA 4.0.

Location

University of Miami Sylvester Comprehensive Cancer Center
1475 Northwest 12th Avenue
Sylvester Support Services Building – Room 110
Miami, FL 33136

Date and Time

Wed, June 14, 2017
3:30 PM – 5:00 PM EDT

 Opening Remarks:

• Christine I. Caly-Sanchez
  Associate Director/Project Manager, Miami-Florida EU Jean Monnet Center of Excellence, FIU

• Dr. Alice A. Tomei
  Assistant Professor, Dept. of Biomedical Engineering; Director, Islet Immunoengineering Laboratory, University of Miami

European and American Panelists:

• Dr. Serge Braun
  Chief Scientific Officer, AFM-Telethon
  Member of the French National Academy of Pharmacy (France)

• Dr. Tarek R. Fadel
  Assistant Director, The Marble Center for Cancer Nanomedicine, The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge MA

• Dr. Babak Kateb
  M.D. Scientific Director & Chief Strategy Officer (CSO)| California Neurosurgical Institute | Los Angeles, CA|
  Founding Chairman of the Board of Directors| CEO and Scientific Director| Society for Brain Mapping & Therapeutics (SBMT)|

Presentation on Horizon 2020 by:

• Henriette Krimphoff
  Senior Scientific Officer, German Aerospace Center, DLR Project Management Agency (Germany)

• Viktoria Bodnarova
  EURAXESS Links North America Regional Representative

University of Miami Panelists:

• Dr. Agarwal Ashutosh
  Assistant Professor, Pathology & Biomedical Engineering, Dr. John T. Macdonald Foundation Biomedical Nanotechnology, University of Miami Miller School of Medicine

• Dr. Spana Deo
  Associate Professor, Biochemistry and Molecular Biology
  University of Miami Miller School of Medicine

• Dr. Sung Jin Kim
  Assistant Professor, Electrical and Computer Engineering, University of Miami College of Engineering

• Dr. Francisco M. Raymo
  Professor of Chemistry, Laboratory of Molecular Photonics, Dept. of Chemistry

• Dr. Alice A. Tomei
  Assistant Professor, Dept. of Biomedical Engineering; Director, Islet Immunoengineering Laboratory, University of Miami

To view bios, click here

To view flyer, click here